Long Covid Labs
Accelerating a cure for 100M Long COVID patients. By incentivizing scientists, patients and supporters to collaborate and share data, we’re creating an open marketplace for rapid R&D and commercialization of new treatments for Long COVID. Our first treatment launches January 2025.
Long COVID is the fastest-growing chronic health condition in human history. It's already estimated to cost the global economy more than $1 trillion dollars or 1% of global GDP each year.
400 Million
Global cumulative patient population
$1 Trillion
Global Cost Yearly
Zero
Number of Long COVID treaments approved
Project
Additional Documentation
10% of COVID infections result in Long COVID. The virus can be found in the body and brain for years after the initial infection, potentially causing worrying health effects in Long COVID and beyond.
Yet even as governments have spent over $1 billion to fund basic research, there's been very little progress on medical treatment.
Case in point: not a single drug has been approved anywhere in the world to treat Long COVID.
Our founder Rohan Dixit was a former neuroscientist who self-experimented and cured his own Long COVID. LCL is now launching decentralized clinical trials on the DAO's first treatment candidate, based on Rohan's experience with combination monoclonal antibody and replication inhibitor drugs.
The government has abandoned mitigation efforts and slow-walked more funding for Long COVID treatments. Big Pharma is ignoring this area, and people are losing hope.
Long Covid Labs (LCL) aims to accelerate breakthrough treatments to cure the 100M+ Long Covid patients still struggling to find solutions.
Updates
Stay up to date
Get the latest community updates and find out about upcoming Long Covid Labs developments